Our team

Our team of professionals and experts

Memel Biotech team is a group of experienced and highly motivated life sciences and medicine professionals. Our international team provides expertise in ATMP development, product development services, biopharmaceutical manufacturing, regulatory support services, precision medicine research, drug development, and commercialization.

Our team

Olga Potapova, PhD

Co-Founder and CSO

  • 30+ years of leadership in R&D and research management: human genetics, signal transduction in aging and cancer, diagnostics, translational & precision medicine
  • International recognition in the fields of biobanking, laboratory service, and management of multinational preclinical and clinical research programs
  • Academic, biotech and big pharma R&D experience:
    • Excellence in translational medicine and drug development (SUTENT) 
    • Founder & CEO of Cureline, Inc., 2003
    • Co-Founder & Managing Partner, Cureline BioPathology LLC, 2008
    • TCGA and CPTAC Principal Investigator, 2010
    • President, BioCrypton, Inc., 2014
    • Managing Partner, Cureline Molecular Services, 2019
    • Founder and CEO, Cureline Baltic UAB, 2020
    • Founder and CSO, DolceRx Baltika UAB, 2021
    • Co-Founder and CSO, Memel Biotech UAB, 2023.
Agnė Vaitkevičienė, MS

Co-Founder and CEO

  • BS in Molecular biology and MS in Cell therapy 
  • 15+ years of experience in Life Science industry
  • Excellence in ATMP, iATMP, GMP, EU regulatory, cell therapy, tissue and cell banking, biotechnology product development, technology transfer management in EU. Experience in cell therapy, advanced therapy medicinal product development and manufacturing
  • Outstanding leadership and expertise in biomedical research and clinical project management and attraction of funding for R&D projects
  • Extensive global professional network (life science)
  • EU funding program expert (IMI2, EIT Health Innostars) and national Lithuanian expert for Science and Innovation Agency
  • Vice-president and board member of LithuaniaBIO, Board member of Vilnius University Life Science Center and Center for Innovative Medicine, Lithuania, as well as expert in governmental and funding programs for life science and biotechnology. 
  • Lecturer at Vilnius University and Klaipeda University
  • Joined Cureline Group in 2020 as COO of Cureline Baltic UAB
  • CEO, DolceRx Baltika UAB, 2021
  • Co-Founder and CEO, Memel Biotech UAB, 2023.